IGC Pharma, Inc. (IGC) › Total LiabilitiesIGC Pharma, Inc. (IGC) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2011: $7.79M2012: $9.44M2013: $4.28M2014: $3.59M2015: $5.58M2016: $4.91M2017: $3.93M2018: $2.79M2019: $893.0K2020: $2.45M2021: $3.06M2022: $2.94M2023: $2.27M2024: $2.58M2025: $2.29M$2.29M2011Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$2.29M-11.3%2024$2.58M+13.9%2023$2.27M-22.9%2022$2.94M-4.0%2021$3.06M+25.2%2020$2.45M+174.0%2019$893.0K-68.0%2018$2.79M-29.1%2017$3.93M-19.9%2016$4.91M-12.0%2015$5.58M+55.5%2014$3.59M-16.1%2013$4.28M-54.7%2012$9.44M+21.3%2011$7.79M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share